Delivery of FGF10 by implantable porous gelatin microspheres for treatment of spinal cord injury

Gu,Yuntao; Wen,Guangyu; Zhao,Hai; Qi,Hao; Yang,Yi; Hu,Tianqiong

doi:10.3892/mmr.2023.13024

Delivery of FGF10 by implantable porous gelatin microspheres for treatment of spinal cord injury

Authors:
- Yuntao Gu
- Guangyu Wen
- Hai Zhao
- Hao Qi
- Yi Yang
- Tianqiong Hu
View Affiliations

Affiliations: Department of Spinal Surgery, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan 570311, P.R. China
Published online on: May 26, 2023 https://doi.org/10.3892/mmr.2023.13024
Article Number: 137
Copyright: © Gu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Porous gelatin microspheres (GMSs) were constructed to enhance the neuroprotective effects of fibroblast growth factor 10 (FGF10) against spinal cord injury (SCI). The GMSs were prepared using a water‑in‑oil emulsion, followed by cross‑linking, washing and drying. The blank GMSs had a mean particle size of 35 µm, with a coarse and porous surface. FGF10 was encapsulated within bulk GMSs via diffusion. To evaluate the effects of the FGF10‑GMSs, locomotion tests were performed as a measure of the functional recovery of rats. Hematoxylin and eosin and Nissl staining were used to quantify tissue injury, and Evans blue staining was used to evaluate blood‑spinal cord barrier restoration. Western blotting and TUNEL assays were employed to assess apoptotic activity. Immunohistochemical staining of neurofilament antibodies (NF200) was used to evaluate axonal rehabilitation. Compared with the groups intravenously administered FGF10 alone, disruption of the blood‑spinal cord barrier and tissue injury were attenuated in the FGF10‑GMS group; this group also showed less neuronal apoptosis, as well as enhanced neuronal and axonal rehabilitation. Implantable porous GMSs could serve as carriers for FGF10 in the treatment of SCI.

View Figures

View References

1	Ren H, Han M, Zhou J, Zheng ZF, Lu P, Wang JJ, Wang JQ, Mao QJ, Gao JQ and Ouyang HW: Repair of spinal cord injury by inhibition of astrocyte growth and inflammatory factor synthesis through local delivery of flavopiridol in PLGA nanoparticles. Biomaterials. 35:6585–6594. 2014. View Article : Google Scholar : PubMed/NCBI
2	Anjum A, Yazid MD, Fauzi Daud M, Idris J, Ng AMH, Selvi Naicker A, Ismail OHR, Athi Kumar RK and Lokanathan Y: Spinal cord injury: Pathophysiology, multimolecular interactions, and underlying recovery mechanisms. Int J Mol Sci. 21:75332020. View Article : Google Scholar : PubMed/NCBI
3	Zhang Y, Al Mamun A, Yuan Y, Lu Q, Xiong J, Yang S, Wu C, Wu Y and Wang J: Acute spinal cord injury: Pathophysiology and pharmacological intervention (Review). Mol Med Rep. 23:4172021. View Article : Google Scholar : PubMed/NCBI
4	Kawabata S, Takano M, Numasawa-Kuroiwa Y, Itakura G, Kobayashi Y, Nishiyama Y, Sugai K, Nishimura S, Iwai H, Isoda M, et al: Grafted Human iPS cell-derived oligodendrocyte precursor cells contribute to robust remyelination of demyelinated axons after spinal cord injury. Stem Cell Reports. 6:1–8. 2016. View Article : Google Scholar : PubMed/NCBI
5	Zhang HY, Wang ZG, Wu FZ, Kong XX, Yang J, Lin BB, Zhu SP, Lin L, Gan CS, Fu XB, et al: Regulation of autophagy and ubiquitinated protein accumulation by bFGF promotes functional recovery and neural protection in a rat model of spinal cord injury. Mol Neurobiol. 48:452–464. 2013. View Article : Google Scholar : PubMed/NCBI
6	Assinck P, Duncan GJ, Plemel JR, Lee MJ, Stratton JA, Manesh SB, Liu J, Ramer LM, Kang SH, Bergles DE, et al: Myelinogenic plasticity of oligodendrocyte precursor cells following spinal cord contusion injury. J Neurosci. 37:8635–8654. 2017. View Article : Google Scholar : PubMed/NCBI
7	Kim M, Kim KH, Song SU, Yi TG, Yoon SH, Park SR and Choi BH: Transplantation of human bone marrow-derived clonal mesenchymal stem cells reduces fibrotic scar formation in a rat spinal cord injury model. J Tissue Eng Regen Med. 12:e1034–e1045. 2018. View Article : Google Scholar : PubMed/NCBI
8	Itoh N and Ohta H: Fgf10: A paracrine-signaling molecule in development, disease, and regenerative medicine. Curr Mol Med. 14:504–509. 2014. View Article : Google Scholar : PubMed/NCBI
9	Chao CM, Moiseenko A, Zimmer KP and Bellusci S: Alveologenesis: Key cellular players and fibroblast growth factor 10 signaling. Mol Cell Pediatr. 3:172016. View Article : Google Scholar : PubMed/NCBI
10	Li YH, Fu HL, Tian ML, Wang YQ, Chen W, Cai LL, Zhou XH and Yuan HB: Neuron-derived FGF10 ameliorates cerebral ischemia injury via inhibiting NF-κB-dependent neuroinflammation and activating PI3K/Akt survival signaling pathway in mice. Sci Rep. 6:198692016. View Article : Google Scholar : PubMed/NCBI
11	Dong L, Li R, Li D, Wang B, Lu Y, Li P, Yu F, Jin Y, Ni X, Wu Y, et al: FGF10 enhances peripheral nerve regeneration via the preactivation of the PI3K/Akt signaling-mediated antioxidant response. Front Pharmacol. 10:12242019. View Article : Google Scholar : PubMed/NCBI
12	Chen J, Wang Z, Zheng Z, Chen Y, Khor S, Shi K, He Z, Wang Q, Zhao Y, Zhang H, et al: Neuron and microglia/macrophage-derived FGF10 activate neuronal FGFR2/PI3K/Akt signaling and inhibit microglia/macrophages TLR4/NF-κB-dependent neuroinflammation to improve functional recovery after spinal cord injury. Cell Death Dis. 8:e30902017. View Article : Google Scholar : PubMed/NCBI
13	Farooq M, Khan AW, Kim MS and Choi S: The role of fibroblast growth factor (FGF) signaling in tissue repair and regeneration. Cells. 10:32422021. View Article : Google Scholar : PubMed/NCBI
14	Turner N and Grose R: Fibroblast growth factor signalling: From development to cancer. Nat Rev Cancer. 10:116–129. 2010. View Article : Google Scholar : PubMed/NCBI
15	Chen L, Zhang Y, Yin L, Cai B, Huang P, Li X and Liang G: Fibroblast growth factor receptor fusions in cancer: Opportunities and challenges. J Exp Clin Cancer Res. 40:3452021. View Article : Google Scholar : PubMed/NCBI
16	Hui Q, Jin Z, Li X, Liu C and Wang X: FGF family: From drug development to clinical application. Int J Mol Sci. 19:18752018. View Article : Google Scholar : PubMed/NCBI
17	Chang SS, Yokomise H, Matsuura N, Gotoh M and Tabata Y: Novel therapeutic approach for pulmonary emphysema using gelatin microspheres releasing basic fibroblast growth factor in a canine model. Surg Today. 44:1536–1541. 2014. View Article : Google Scholar : PubMed/NCBI
18	Jin Y, Kim IY, Kim ID, Lee HK, Park JY, Han PL, Kim KK, Choi H and Lee JK: Biodegradable gelatin microspheres enhance the neuroprotective potency of osteopontin via quick and sustained release in the post-ischemic brain. Acta Biomater. 10:3126–3135. 2014. View Article : Google Scholar : PubMed/NCBI
19	Kempen DH, Lu L, Heijink A, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ and Dhert WJ: Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials. 30:2816–2825. 2009. View Article : Google Scholar : PubMed/NCBI
20	Lan L, Tian FR, ZhuGe DL, ZhuGe QC, Shen BX, Jin BH, Huang JP, Wu MZ, Fan LX, Zhao YZ and Xu HL: Implantable porous gelatin microspheres sustained release of bFGF and improved its neuroprotective effect on rats after spinal cord injury. PLoS One. 12:e01738142017. View Article : Google Scholar : PubMed/NCBI
21	Minardi S, Pandolfi L, Taraballi F, De Rosa E, Yazdi IK, Liu X, Ferrari M and Tasciotti E: PLGA-Mesoporous silicon microspheres for the in vivo controlled temporospatial delivery of proteins. ACS Appl Mater Interfaces. 7:16364–16373. 2015. View Article : Google Scholar : PubMed/NCBI
22	Wang Q, He Y, Zhao Y, Xie H, Lin Q, He Z, Wang X, Li J, Zhang H, Wang C, et al: A thermosensitive heparin-poloxamer hydrogel bridges aFGF to treat spinal cord injury. ACS Appl Mater Interfaces. 9:6725–6745. 2017. View Article : Google Scholar : PubMed/NCBI
23	Basso DM, Beattie MS and Bresnahan JC: A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 12:1–21. 1995. View Article : Google Scholar : PubMed/NCBI
24	Zheng B, Ye L, Zhou Y, Zhu S, Wang Q, Shi H, Chen D, Wei X, Wang Z, Li X, et al: Epidermal growth factor attenuates blood-spinal cord barrier disruption via PI3K/Akt/Rac1 pathway after acute spinal cord injury. J Cell Mol Med. 20:1062–1075. 2016. View Article : Google Scholar : PubMed/NCBI
25	Liu WG, Wang ZY and Huang ZS: Bone marrow-derived mesenchymal stem cells expressing the bFGF transgene promote axon regeneration and functional recovery after spinal cord injury in rats. Neurol Res. 33:686–693. 2011. View Article : Google Scholar : PubMed/NCBI
26	Xin DQ, Hu ZM, Huo HJ, Yang XJ, Han D, Xing WH, Zhao Y and Qiu QH: Schisandrin B attenuates the inflammatory response, oxidative stress and apoptosis induced by traumatic spinal cord injury via inhibition of p53 signaling in adult rats. Mol Med Rep. 16:533–538. 2017. View Article : Google Scholar : PubMed/NCBI
27	Beenken A and Mohammadi M: The FGF family: Biology, pathophysiology and therapy. Nat Rev Drug Discov. 8:235–253. 2009. View Article : Google Scholar : PubMed/NCBI
28	Nakaguchi K, Jinnou H, Kaneko N, Sawada M, Hikita T, Saitoh S, Tabata Y and Sawamoto K: Growth factors released from gelatin hydrogel microspheres increase new neurons in the adult mouse brain. Stem Cells Int. 2012:9151602012. View Article : Google Scholar : PubMed/NCBI
29	Rong Y, Liu W, Wang J, Fan J, Luo Y, Li L, Kong F, Chen J, Tang P and Cai W: Neural stem cell-derived small extracellular vesicles attenuate apoptosis and neuroinflammation after traumatic spinal cord injury by activating autophagy. Cell Death Dis. 10:3402019. View Article : Google Scholar : PubMed/NCBI
30	Jia G, Zhang Y, Li W and Dai H: Neuroprotective role of icariin in experimental spinal cord injury via its antioxidant, antineuroinflammatory and antiapoptotic properties. Mol Med Rep. 20:3433–3439. 2019.PubMed/NCBI
31	Lee JY, Kim HS, Choi HY, Oh TH and Yune TY: Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood-spinal cord barrier after spinal cord injury. Brain. 135:2375–2389. 2012. View Article : Google Scholar : PubMed/NCBI